p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Authors:
- Annemieke IjpenbergAIAnnemieke Ijpenberg
- Ji-Ying SongJSJi-Ying Song
- Martin van der ValkMVMartin van der Valk
- Martijn NawijnMNMartijn Nawijn
- John ZevenhovenJZJohn Zevenhoven
- Anton BernsABAnton Berns
Top Cited Papers
- 1 August 2007
- journal article
- Published by Springer Nature in Nature
- Vol. 448 (7156) , 943-946
Abstract
The CDKN2b-CDKN2a locus on chromosome 9p21 in human (chromosome 4 in mouse) is frequently lost in cancer. The locus encodes three cell cycle inhibitory proteins: p15INK4b encoded by CDKN2b, p16INK4a encoded by CDKN2a and p14ARF (p19Arf in mice) encoded by an alternative reading frame of CDKN2a (ref. 1). Whereas the tumour suppressor functions for p16INK4a and p14ARF have been firmly established, the role of p15INK4b remains ambiguous. However, many 9p21 deletions also remove CDKN2b, so we hypothesized a synergistic effect of the combined deficiency for p15INK4b, p14ARF and p16INK4a. Here we report that mice deficient for all three open reading frames (Cdkn2ab-/-) are more tumour-prone and develop a wider spectrum of tumours than Cdkn2a mutant mice, with a preponderance of skin tumours and soft tissue sarcomas (for example, mesothelioma) frequently composed of mixed cell types and often showing biphasic differentiation. Cdkn2ab-/- mouse embryonic fibroblasts (MEFs) are substantially more sensitive to oncogenic transformation than Cdkn2a mutant MEFs. Under conditions of stress, p15Ink4b protein levels are significantly elevated in MEFs deficient for p16Ink4a. Our data indicate that p15Ink4b can fulfil a critical backup function for p16Ink4a and provide an explanation for the frequent loss of the complete CDKN2b-CDKN2a locus in human tumours.Keywords
This publication has 22 references indexed in Scilit:
- Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for allNature Reviews Molecular Cell Biology, 2006
- Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathwaysBritish Journal of Dermatology, 2006
- Tumor suppressor genes in normal and malignant hematopoiesisOncogene, 2002
- Loss of p16Ink4a confers susceptibility to metastatic melanoma in miceNature, 2001
- Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesisNature, 2001
- Alterations of INK4A and INK4B Genes in Adult Soft Tissue Sarcomas: Effect on SurvivalJNCI: Journal of the National Cancer Institute, 1999
- Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cellsLeukemia, 1998
- The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53Cell, 1998
- Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19Cell, 1997
- Role of the INK4a Locus in Tumor Suppression and Cell MortalityCell, 1996